Clinical Trial Update: Acute Hemostasis Following the Use of the AQUABEAM® System for the Treatment of Benign Prostatic Hyperplasia II [NA]

View source ↗

Summary

A completed clinical trial evaluating acute hemostasis after using the AQUABEAM System for treating benign prostatic hyperplasia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Benign Prostatic Hyperplasia

Drugs mentioned

• AQUABEAM System

Snippet

Sponsor: PROCEPT BioRobotics | Conditions: Benign Prostatic Hyperplasia | NA | Status: COMPLETED